ArticleTherapeutic advances in neurological disorders2022

Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.

Tobias Moser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.